The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis

Rheumatology 2014;53: 1344–1346 , doi: 10.1093/rheumatology/keu168 In the above guideline, the sentence: ‘NICE has accredited the process used by the BSR to produce its treatment of psoriatic arthritis with biologics guidance.’, should read: ‘NICE has accredited the process used by the BSR to produce its treatment of adult rheumatoid arthritis with intravenous tocilizumab guidance.’